Compare Strategy Inc. (MSTR) vs Novartis AG (NVS) Price & Performance

Strategy Inc.Trade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

Strategy Inc. vs Novartis AG — how do they compare? Strategy Inc. trades at $101.61 (market cap $35.47B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 8.2× Strategy Inc.'s market cap, and Novartis AG pays a 3.17% dividend while Strategy Inc. pays none. Which is the better fit depends on your goals.

	MSTR	NVS
Market Cap	$35.47B	$290.25B
Sector	Technology	Health
52-Week High	$426.40	$168.62
52-Week Low	$82.31	$113.50
Enterprise Value	$50.50B	$330.27B
Dividend Yield	—	3.17%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MSTR

Crypto stocks move in premarket after Senate hearings on US crypto legislation.FXEmpire · 14 hours agoNeutral View details →

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 1 day agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 5 days agoBullish View details →

About Strategy Inc.

MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.